Trial
NCT04338828
Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
COVID19
Intervention
Nitric Oxide Gas
Why stopped
Absence of patients meeting criteria following initial COVID surge. DMSB recommended analysis of results to date and early closure.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-06